摘要
以银杏叶制剂的全球专利数据为分析样本,从专利的申请量、技术分布、申请人等多个角度详细分析了国内外相关专利的整体进展状况。研究表明,欧洲和中国是银杏叶制剂研发和专利申请的最重要地区;欧洲申请人起步最早,发展平稳,专利的质量最高;我国申请人起步虽晚,却发展迅速,在该领域已经具备一定的研发实力,但在专利的质量上仍有待提高。该研究结果为银杏叶制剂的开发提供了参考,建议中国申请人在研究中充分吸收借鉴他人的专利技术和布局经验,提升新药研发及专利保护的水平。
With related global patent data as analysis samples, worldwide patent overview of Ginkgo biloba preparation is ana- lyzed in application, applicant, technical distribution and so on. This research shows that the most important areas of G. biloba prepara-tion are Europe and China. The European applicants start earliest along with developing smoothly, moreover, their patents have best qual- ity. The Chinese applicants start late along with the fastest growing, and have already certain research capabilities, moreover, their pa- tents' quality needs to be improved. This research result provides reference for development of G. biloba preparation. The author suggest that Chinese applicants learn techniques and layout experiences of other's patents fully to enhance the level of new drug development and patent protection.
出处
《中国中药杂志》
CAS
CSCD
北大核心
2013年第17期2889-2893,共5页
China Journal of Chinese Materia Medica
基金
教育部人文社会科学研究青年基金项目(10YJCZH095)
北京中医药大学科研创新团队项目(2011-CXTD-15)
关键词
银杏叶
专利
分析
Ginkgo biloba
patent
analysis